Amylyx Pharmaceuticals, Inc. (AMLX)
13.42
-0.13
(-0.96%)
USD |
NASDAQ |
Jun 10, 14:11
Amylyx Pharmaceuticals EPS Diluted (TTM) : -1.507 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alumis, Inc. | -1.921 |
| Merck & Co., Inc. | 3.553 |
| Ocular Therapeutix, Inc. | -1.456 |
| ANI Pharmaceuticals, Inc. | 3.942 |
| Corcept Therapeutics, Inc. | 0.35 |